Collecting clinical data from patients with lymphoid malignancies
The ARCAN Database is Used for Retrospective Non-interventional Research Projects. The Database Collects Clinical and Laboratory Data From Patients With Lymphoid Malignancies. The Database Doesn't Require Biological Sample of Patients, it Records Only Information Based on the Patients' Medical File.
This study is collecting medical information from patients with lymphoid cancers to see how well different treatments work and their side effects.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 13000 (estimated) |
| Ages | 16 Years and up |
| Sex | All |
| Sponsor | Hospices Civils de Lyon Academic / other |
| Locations | 1 site (Pierre-Bénite) |
| Trial ID | NCT03868527 on ClinicalTrials.gov |
What this trial studies
This study utilizes the ARCAN database to gather retrospective clinical and laboratory data from patients diagnosed with lymphoid malignancies. It aims to analyze the diagnostic and therapeutic approaches, including efficacy and toxicity, for these patients managed in the hematology department. The study is observational and does not involve any biological samples, relying solely on information from patients' medical files. By compiling this data, the study seeks to enhance understanding of treatment outcomes in hematologic diseases.
Who should consider this trial
Good fit: Ideal candidates for this study are patients receiving treatment for hematological diseases at Lyon Sud Hospital.
Not a fit: Patients without hematological diseases will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve treatment strategies and patient outcomes for those with lymphoid malignancies.
How similar studies have performed: Other studies utilizing similar retrospective data collection methods have shown success in improving treatment understanding and outcomes in hematologic conditions.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: - Patients followed for hematological diseases in Lyon Sud Hospital Exclusion Criteria: - Patients who doesn't have hematological diseases
Where this trial is running
Pierre-Bénite
- Hôpital Lyon Sud — Pierre-Bénite, France (Recruiting)
Study contacts
- Principal investigator: Gilles Salles, MD — Hospices Civils de Lyon
- Study coordinator: Gilles Salles, MD
- Email: gilles.salles@chu-lyon.fr
- Phone: 0478864307
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.